Revium Rx (RVRC) Cash & Equivalents (2024 - 2025)
Revium Rx (RVRC) reported Cash & Equivalents of $1.7 million for Q4 2025, down 48.65% on a YoY basis from $3.3 million in Q4 2024, and down 48.65% sequentially from $3.3 million in Q4 2024.
Revium Rx (RVRC) Cash & Equivalents (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Cash & Equivalents data on file, last reported at $1.7 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 48.65% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 48.65% YoY), and the FY2025 full-year result was $1.7 million, down 48.65% from the prior year.
- Cash & Equivalents slipped to $1.7 million in Q4 2025, from $3.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $3.3 million in Q4 2024 to a low of $1.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.44 Bn | 24.13 Bn | 662.02 Mn | 1.90 Bn |
| 2 | BrightSpring Health Services | 14.93 Bn | 14.03 Bn | 482.22 Mn | 888.80 Mn |
| 3 | Healthequity | 8.11 Bn | 7.84 Bn | 256.31 Mn | 265.37 Mn |
| 4 | 10x Genomics | 6.00 Bn | 5.46 Bn | 106.18 Mn | 490.29 Mn |
| 5 | Hinge Health | 5.95 Bn | 5.63 Bn | 154.23 Mn | 186.67 Mn |
| 6 | MiniMed | 4.43 Bn | 4.13 Bn | 480.00 Mn | 298.00 Mn |
| 7 | Waystar Holding | 4.39 Bn | 4.32 Bn | 216.84 Mn | 34.34 Mn |
| 8 | Doximity | 3.91 Bn | 3.16 Bn | 125.97 Mn | 219.18 Mn |
| 9 | Privia Health | 3.19 Bn | 2.77 Bn | - | 419.52 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 3.27 Mn |